United Therapeutics Corp. (UTHR)
513.04
-0.08
(-0.02%)
USD |
NASDAQ |
Aug 24, 16:00
513.04
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics EPS Diluted (Quarterly) : 7.271 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.271 |
| March 31, 2026 | 5.824 |
| December 31, 2025 | 7.702 |
| September 30, 2025 | 7.161 |
| June 30, 2025 | 6.408 |
| March 31, 2025 | 6.630 |
| December 31, 2024 | 6.187 |
| September 30, 2024 | 6.386 |
| June 30, 2024 | 5.855 |
| March 31, 2024 | 6.169 |
| December 31, 2023 | 4.359 |
| September 30, 2023 | 5.384 |
| June 30, 2023 | 5.236 |
| March 31, 2023 | 4.857 |
| December 31, 2022 | 2.674 |
| September 30, 2022 | 4.914 |
| June 30, 2022 | 2.412 |
| March 31, 2022 | 5.029 |
| December 31, 2021 | 2.347 |
| September 30, 2021 | 3.418 |
| June 30, 2021 | 3.649 |
| March 31, 2021 | 0.6099 |
| December 31, 2020 | 2.191 |
| September 30, 2020 | 3.839 |
| June 30, 2020 | 2.412 |
| Date | Value |
|---|---|
| March 31, 2020 | 3.122 |
| December 31, 2019 | 1.195 |
| September 30, 2019 | 3.009 |
| June 30, 2019 | 4.66 |
| March 31, 2019 | -11.32 |
| December 31, 2018 | 1.484 |
| September 30, 2018 | 2.42 |
| June 30, 2018 | 3.98 |
| March 31, 2018 | 5.57 |
| December 31, 2017 | 0.43 |
| September 30, 2017 | 6.27 |
| June 30, 2017 | -1.25 |
| March 31, 2017 | 3.89 |
| December 31, 2016 | 2.43 |
| September 30, 2016 | 3.50 |
| June 30, 2016 | 4.39 |
| March 31, 2016 | 4.84 |
| December 31, 2015 | 2.10 |
| September 30, 2015 | 9.24 |
| June 30, 2015 | 1.91 |
| March 31, 2015 | -0.36 |
| December 31, 2014 | 2.17 |
| September 30, 2014 | -0.53 |
| June 30, 2014 | 2.10 |
| March 31, 2014 | 2.43 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liquidia Corp. | 0.7369 |
| Insmed, Inc. | -0.0609 |
| MannKind Corp. | -0.0616 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| BioMarin Pharmaceutical, Inc. | 0.2302 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 333.00M |
| Revenue (Quarterly) | 783.30M |
| Total Expenses (Quarterly) | 450.30M |
| Enterprise Value | 19.24B |
| Gross Profit Margin (Quarterly) | 87.30% |
| Profit Margin (Quarterly) | 42.51% |
| Earnings Yield | 5.45% |
| Operating Earnings Yield | 5.83% |
| Normalized Earnings Yield | 5.085 |